AGM Information • Jun 30, 2025
AGM Information
Open in ViewerOpens in native device viewer


On 27-6-2025, the Annual Ordinary General Meeting of the Company's Shareholders was held, in which 12 shareholders representing 70,781,132 shares and voting rights, i.e. 81.61% of the total number of shares, participated and therefore the General Meeting was legally quorate for the discussion and decision-making on all items on the agenda.
The General Meeting with the above quorum adopted the following resolutions:
1.Submission and approval of the Annual Financial Statements of the Company for the fiscal year 2024 (1.1.2024 - 31.12.2024) on a consolidated and nonconsolidated basis, including the Sustainability Report in accordance with Law 5164/2024, the statements of the representatives of the Board of Directors provided for in Art. 4 of law 3556/2007, the Corporate Governance Statement pursuant to Law 4548/2018 and Law 4706/2020, as well as the relevant Reports of the Board of Directors and the Auditors.
The General Meeting approved by majority vote the Annual Financial Report for the Company's fiscal year 01/01/2024 - 31/12/2024, which includes the Company's Annual Financial Statements for the fiscal year 2024 (1.1.2024 - 31.12.2024) on a consolidated and non-consolidated basis, including the Sustainability Report in accordance with Law 5164/2024, the statements of the representatives of the Board of Directors provided for in Art. 4 of law 3556/2007, the Corporate Governance Statement pursuant to Law 4548/2018 and Law 4706/2020, as well as the relevant Reports of the Board of Directors and the Auditors, as approved by the Board of Directors on 29-4-2025. APPROVED BY 70,780,980 SHARES 100%



AGAINST - SHARES 0% ABSTAIN 152 SHARES 0%
2. Approval of the overall management of the Company by the Board of Directors for the fiscal year 2024 in accordance with article 108 of Law 4548/2018.
The General Meeting approved by majority vote the overall management of the Company conducted by the Board of Directors for the Annual Financial Statements and the operations of the Company for the fiscal year 01/01/2024 - 31/12/2024.
APPROVED BY 70,780,980 SHARES 100% AGAINST - SHARES 0% ABSTAIN 152 SHARES 0%
The General Meeting unanimously released the Statutory Auditor from any liability for compensation for the Annual Financial Statements and the activities for the fiscal year 01/01/2024 - 31/12/2024.
| APPROVED BY | 70,781,132 | SHARES 100% |
|---|---|---|
| AGAINST | - | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
4. Approval of the remuneration of members of the Board of Directors and members of the Audit Committee for fiscal year 2024 and pre-approval of the remuneration of members of the Board of Directors and the Audit Committee for fiscal year 2025.
The General Meeting approved by majority vote the remuneration of the members of the Board of Directors for their services rendered to the Company in fiscal year 2024


and pre-approved the remuneration of the members of the Board of Directors for fiscal year 2025.
Furthermore, the General Meeting approved by majority vote the remuneration of the members of the Audit Committee for the fiscal year 2024 and pre-approved the remuneration of the members of the Audit Committee for the fiscal year 2025.
| APPROVED BY | 70,780,980 | SHARES 100% |
|---|---|---|
| AGAINST | 152 | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
The General Meeting unanimously approved the fee of the auditing company "Grant Thornton SA, Chartered Accountants and Business Consultants", SOEL number 127, for the regular and tax audit of the Company's fiscal year (01/01/2024-31/12/2024).
| APPROVED BY | 70,781,132 | SHARES 100% |
|---|---|---|
| AGAINST | - | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
The General Meeting elected, taking into account the recommendation of the Audit Committee to the Board of Directors, the audit firm "Grant Thornton SA, Chartered Accountants and Business Consultants" with number SOEL 127, for the Corporate Year 01/01/2025 - 31/12/2025.
Subsequently, the General Meeting pre-approved the fees of the auditing company "Grant Thornton SA, Chartered Accountants and Business Consultants" with the number SOEL 127, for the regular and tax audit for the Corporate Year (01/01/2025- 31/12/2025).


| APPROVED BY | 70,780,980 | SHARES 100% |
|---|---|---|
| AGAINST | 152 | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
The General Meeting elected, taking into account the recommendation of the Audit Committee to the Board of Directors, the audit firm "Grant Thornton SA" with number SOEL 127, for the (limited) assurance on the Sustainability Report for the fiscal year 2025.
Subsequently, the General Meeting pre-approved the fees of the auditing company "Grant Thornton SA, Chartered Accountants and Business Consultants" with the number SOEL 127, for the (limited) assurance on the Sustainability Report for the fiscal year 2025.
| APPROVED BY | 70,780,980 | SHARES 100% |
|---|---|---|
| AGAINST | 152 | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
8. Submission to the Ordinary General Meeting of Shareholders of the Remuneration Report of the members of the Board of Directors for the fiscal year 1/1/2024- 31/12/2024 in accordance with article 112 par. 3 of Law 4548/2018.
In the eighth (8th) item of the Agenda, the report on the remuneration of the members of the Board of Directors for the financial year 1/1/2023-31/12/2023 pursuant to article 112 par. 3 of Law No. 4548/2018 and advisory vote.
| APPROVED BY | 70,780,980 | SHARES 100% |
|---|---|---|
| AGAINST | 152 | SHARES 0% |
| ABSTAIN | - | SHARES 0% |


9. Submission to the Ordinary General Meeting of the Annual Report of the Audit Committee for the fiscal year 2024, in accordance with the provisions of article 44, para. 1 of Law 4449/2017, as replaced by article 74 para. 4 of Law 4706/2020. In the ninth (9th) item of the Agenda, the annual report of the Audit Committee's activities was submitted to the Ordinary General Meeting in accordance with the provisions of Article 74 of Law 4706/2020, on which no comments were made. Item 9th is of an informative nature and is not put to a vote.
In the tenth (10th) item of the Agenda, the Report of the independent non-executive members of the Board of Directors dated 21-5-2025 was submitted to the General Meeting in accordance with the provision of Article 9, Para. 5 of Law 4706/2020. The 10th item is a notice to the General Meeting and is not put to a vote.
In the eleventh (11th) item of the Agenda, the General Assembly approved the Revision of the Remuneration Policy of the members of the Board of Directors and the Chief Managing Director pursuant to article 110 of Law 4548/2018.
| APPROVED BY | 39,143,220 | SHARES 55,302% |
|---|---|---|
| AGAINST | 31,637,912 | SHARES 44,698% |
| ABSTAIN | - | SHARES 0% |


In the twelfth (12th) item of the Agenda, the General Meeting unanimously approved the Revision of the Eligibility Policy of the members of the Board of Directors in accordance with article 3 of Law 4706/2020.
| APPROVED BY | 70,781,132 | SHARES 100% |
|---|---|---|
| AGAINST | - | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
In the thirteenth (13th) item of the Agenda, the General Meeting unanimously elected a nine-member Board of Directors with a three-year term of office and appointed its independent non-executive members as follows:
Nikolaos Koritsas of Christos, Non-Executive Member
The decision was taken unanimously following the vote, pursuant to, as per Article 18 par. 1 of the law 4706/2020, as in force, relevant recommendation dated 05.06.2025 of the Board of Directors of the Company to the Annual General Meeting of the Company's Shareholders and the proposal of the Remuneration and Nominations Committee of 04.06.2025, and after the fulfilment of the criteria of individual and collective suitability and reliability of the members, in accordance with article 3 of the law 4706/2020, as amended, and the approved Eligibility Policy of the Company, as


well as the requirements of Articles 3Aand 5 of Law 4706/2020, as applicable, on the sufficient gender representation and the total number of independent non-executive members of the Board of Directors of the Company, respectively, i.e. the legal composition of the Board of Directors, and that there are no impediments or incompatibilities in the person of the elected members with regard to the relevant provisions of the legal framework of corporate governance, including the Corporate Governance Code (Greek Corporate Governance Code issued by the Hellenic Chamber of Commerce and Industry on June 2021) applied by the Company, the Company's Operating Regulations and the Company's approved Eligibility Policy.
Furthermore, it has been re-certified that in the person of each of the aforementioned independent non-executive members of the Board of Directors appointed by the Ordinary General Meeting of the Company's Shareholders, namely Messrs. a) Athanasios Askitis b) Alexandra Mikroulea and c) Vasiliki Meggou, apply the independence criteria provided for in article 9 par. 1 and 2 of law 4706/2020, as applicable.
The term of office of the Members of the new Board of Directors of the Company is, according to article 19 par. 4 of the Company's Articles of Association a period of three years, which shall be extended in accordance with the provisions of Article 85, paragraph 1, c of Law 4548/2018, as in force and article 19 par. 4 of the Company's Articles of Association, until the expiration of the deadline within which the next ordinary General Meeting must be convened and until the relevant decision is taken.
| APPROVED BY | 70,781,132 | SHARES 100% |
|---|---|---|
| AGAINST | - | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
14. Appointment of members of the Audit Committee in accordance with article 44 of Law No. 4449/2017.


In the fourteenth (14th) item of the Agenda, the General Assembly unanimously appointed the members of the Audit Committee, with a three-year term of office, coinciding with the term of office of the Board of Directors, as an independent (mixed) Committee, in accordance with article 44 of Law 4449/2017, as in force, and article 20 par. 5 of the Company's Articles of Association and which will be composed of the following persons:
The decision was taken following the relevant recommendation of the Board of Directors of the Company dated 05.06.2025, to the Ordinary General Meeting of the Company's Shareholders, in accordance with the proposal of the Remuneration and Nominations Committee of 04.06.2025, and after having considered that the composition of the Audit Committee is in accordance with the provisions of article 44 of Law 4449/2017 as in force, provided that the members of the Audit Committee as a whole have a proven and sufficient knowledge of the sector in which the Company operates, while the majority of its members (i.e. two of the three members, Mr. Agisilaos Panagakos and Alexandra Mikroulea) fully meet the criteria and conditions of independence set forth in article 9 of Law 4706/2020. Mr. Agisilaos Panagakos, one of the members, has sufficient knowledge and experience in accounting matters. The Chairman of the Audit Committee will be determined by the members of the Committee at the constituent meeting of the Committee.
| APPROVED BY | 70,781,132 | SHARES 100% |
|---|---|---|
| AGAINST | - | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
15. Expansion of the purpose of the Company. Amendment of Article 2 of the Company's Articles of Association and codification thereof.


In the fifteenth (15th) item of the Agenda, the General Meeting unanimously decided to broaden the purpose of the company and to amend Article 2 of the company's Articles of Association and codify it as follows:
The incorporated Company's object is:

execution of projects or provision of services which belong to the jurisdiction of the Public Bodies according to the application of L. 3389/2005.
For the fulfilment of the object the company can:
| APPROVED BY | 70,781,132 | SHARES 100% |
|---|---|---|
| AGAINST | - | SHARES 0% |
| ABSTAIN | - | SHARES 0% |
Maroussi, 27 June 2025 THE BOARD OF DIRECTORS


Athens Medical Group benefits from accessing knowledge and expertise from Imperial College Healthcare, a leading UK teaching hospital Trust.

5-7, Distomou str., 151 25 Marousi Athens - Greece T +30 210 6287000, F +30 210 6287050 E [email protected]

www.athensmedicalgroup.com
ATHENS MEDICAL CENTER S.A. / Business Registry No 000356301000 / 5-7 Distomou str., Maroussi 15125

Athens Medical Group benefits from accessing knowledge and expertise from Imperial College Healthcare, a leading UK teaching hospital Trust.

5-7, Distomou str., 151 25 Marousi Athens - Greece T +30 210 6287000, F +30 210 6287050 E [email protected]

www.athensmedicalgroup.com
ATHENS MEDICAL CENTER S.A. / Business Registry No 000356301000 / 5-7 Distomou str., Maroussi 15125
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.